Table 1_Repurposing of the small-molecule adrenoreceptor-inhibitor carvedilol for treatment of the fibrotic lung.xlsx by Maria Jordan (10265489)

“…</p>Methods<p>In silico modeling of dysregulated pathways in IPF and screening for putative interfering small molecules identified carvedilol as a promising anti-fibrotic agent. …”

Spatial patterns of LUC in 2035 different scenarios. by Bao Zhou (20670850)

Subjects:

Distribution of total ESs and hotspots under future climate change. by Bao Zhou (20670850)

Subjects:

Weights of each ecosystem service category during the study period. by Bao Zhou (20670850)

Subjects:

Spatio-temporal changes in SDG under multi-scenario spatio-temporal scenarios. by Bao Zhou (20670850)

Subjects:

Weighting settings for land use projections across multiple scenarios. by Bao Zhou (20670850)

Subjects:

Study area. by Bao Zhou (20670850)

Subjects:

LUC in southeast Yunnan under different scenarios in 2035. by Bao Zhou (20670850)

Subjects:

Distribution of ESs and hot and cold spots during the historical period. by Bao Zhou (20670850)

Subjects:

Spatial distribution of ESs. by Bao Zhou (20670850)

Subjects:

Correspondence of support for SDGs across ESs categories. by Bao Zhou (20670850)

Subjects:

Kaplan-Meier curves and time-dependent Cox regression for outcome of mortality. by Jennifer M. Kwan (3350321)

Subjects:

Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. by Jennifer M. Kwan (3350321)

Subjects:

Adverse cardiovascular events by immune checkpoint inhibitor. by Jennifer M. Kwan (3350321)

Subjects:

Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. by Jennifer M. Kwan (3350321)

Subjects:

Minimal dataset. by Jennifer M. Kwan (3350321)

Subjects:

Estimating RSA Variability in Each SCP Condition. by Hikari Otsuka (18605246)

Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019). by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer deaths by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

Hospitalizations for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects: